Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
1445751-71-2
|
| gptkbp:has_legal_status_in_Germany |
NpSG
|
| gptkbp:has_legal_status_in_UK |
gptkb:Class_B
|
| gptkbp:has_legal_status_in_US |
Schedule I (as an analogue)
|
| gptkbp:hasMolecularFormula |
C20H24N2O2
|
| gptkbp:hasSMILES |
COCCNC(=O)c1cn(C2Cc3ccccc3C2)c2ccccc12
|
| gptkbp:heldBy |
synthetic cannabinoid
|
| https://www.w3.org/2000/01/rdf-schema#label |
QM24
|
| gptkbp:IUPACName |
gptkb:1-(2,3-dihydro-1H-inden-2-yl)-N-(2-methoxyethyl)-1H-indole-3-carboxamide
|
| gptkbp:PubChem_CID |
118796153
52085213 |
| gptkbp:relatedTo |
gptkb:indole-3-carboxamide_cannabinoids
synthetic designer drugs |
| gptkbp:bfsParent |
gptkb:MTA_Bus_Company
gptkb:QM_(Queens-Manhattan_Express) |
| gptkbp:bfsLayer |
6
|